Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on January 15, 2007

Circulation. 2007
Published online before print January 15, 2007, doi: 10.1161/CIRCULATIONAHA.106.668392
A more recent version of this article appeared on January 30, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/4/442    most recent
CIRCULATIONAHA.106.668392v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antzelevitch, C.
Right arrow Articles by Wolpert, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antzelevitch, C.
Right arrow Articles by Wolpert, C.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
Medline Plus Health Information
*Cardiac Arrest
*Genetics Home Reference
Related Collections
Right arrow Electrophysiology
Right arrow Clinical genetics
Right arrow Gene expression
Right arrow Ion channels/membrane transport
Right arrow Electrocardiology
Right arrow Echocardiography
Right arrow Genetics of cardiovascular disease
Right arrowRelated Article

Submitted on October 4, 2006
Accepted on November 22, 2006

Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death

Charles Antzelevitch PhD*, Guido D. Pollevick PhD, Jonathan M. Cordeiro PhD, Oscar Casis PhD, Michael C. Sanguinetti PhD, Yoshiyasu Aizawa MD, PhD, Alejandra Guerchicoff PhD, Ryan Pfeiffer BS, Antonio Oliva MD, PhD, Bernd Wollnik MD, Philip Gelber MD, Elias P. Bonaros Jr MD, Elena Burashnikov MS, Yuesheng Wu MD, John D. Sargent PhD, Stefan Schickel MD, Ralf Oberheiden MD, Atul Bhatia MD, Li-Fern Hsu MD, Michel Haïssaguerre MD, Rainer Schimpf MD, Martin Borggrefe MD, and Christian Wolpert MD

From the Masonic Medical Research Laboratory (C.A., G.D.P., J.M.C., H.A., A.G., R.P., A.O., E.B., Y.W.), Utica, NY; Nora Eccles Harrison Cardiovascular Research and Training Institute (O.C., M.C.S., J.D.S.), University of Utah, Salt Lake City, Utah; Center for Molecular Medicine Cologne (B.W.), Institute of Human Genetics, University of Cologne, Germany; Cardiovascular Consultants of Long Island (P.G., E.P.B.), New Hyde Park, NY; Department of Internal Medicine (S.S., R.O.), Academic Hospital Oberhausen, Oberhausen, Germany; University of Wisconsin Medical School (A.B.), Milwaukee, Wis; Hopital Cardiologique du Haut-Leveque (L.-F.H., M.H.), Bordeaux, France; and 1st Department of Medicine-Cardiology (R.S., M.B., C.W.), University Hospital Mannheim, Faculty of Clinical Medicine of the University of Heidelberg, Mannheim, Germany. Dr Oliva is currently at the Catholic University in Rome, Italy.

* To whom correspondence should be addressed. E-mail: ca{at}mmrl.edu.

Background--Cardiac ion channelopathies are responsible for an ever-increasing number and diversity of familial cardiac arrhythmia syndromes. We describe a new clinical entity that consists of an ST-segment elevation in the right precordial ECG leads, a shorter-than-normal QT interval, and a history of sudden cardiac death.

Methods and Results--Eighty-two consecutive probands with Brugada syndrome were screened for ion channel gene mutations with direct sequencing. Site-directed mutagenesis was performed, and CHO-K1 cells were cotransfected with cDNAs encoding wild-type or mutant CACNB2b (Cav{beta}2b), CACNA2D1 (Cav{alpha}2{delta}1), and CACNA1C tagged with enhanced yellow fluorescent protein (Cav1.2). Whole-cell patch-clamp studies were performed after 48 to 72 hours. Three probands displaying ST-segment elevation and corrected QT intervals ≤360 ms had mutations in genes encoding the cardiac L-type calcium channel. Corrected QT ranged from 330 to 370 ms among probands and clinically affected family members. Rate adaptation of QT interval was reduced. Quinidine normalized the QT interval and prevented stimulation-induced ventricular tachycardia. Genetic and heterologous expression studies revealed loss-of-function missense mutations in CACNA1C (A39V and G490R) and CACNB2 (S481L) encoding the {alpha}1- and {beta}2b-subunits of the L-type calcium channel. Confocal microscopy revealed a defect in trafficking of A39V Cav1.2 channels but normal trafficking of channels containing G490R Cav1.2 or S481L Cav{beta}2b-subunits.

Conclusions--This is the first report of loss-of-function mutations in genes encoding the cardiac L-type calcium channel to be associated with a familial sudden cardiac death syndrome in which a Brugada syndrome phenotype is combined with shorter-than-normal QT intervals.


Key words: arrhythmia • genetics • electrophysiology • tachycardia • fibrillation


Related Article:

Issue Highlights
Circulation 2007 115: 427. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Circ. Res.Home page
M. Chahine
Cardiac Metabolic State and Brugada Syndrome: A Link Revealed
Circ. Res., October 9, 2009; 105(8): 721 - 723.
[Full Text] [PDF]


Home page
EuropaceHome page
C. Veltmann, C. Wolpert, F. Sacher, P. Mabo, R. Schimpf, F. Streitner, J. Brade, F. Kyndt, J. Kuschyk, H. Le Marec, et al.
Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges
Europace, October 1, 2009; 11(10): 1345 - 1352.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. F. Sinner, A. Pfeufer, S. Perz, E. Schulze-Bahr, G. Monnig, L. Eckardt, B.-M. Beckmann, H.-E. Wichmann, G. Breithardt, G. Steinbeck, et al.
Spontaneous Brugada electrocardiogram patterns are rare in the German general population: results from the KORA study
Europace, October 1, 2009; 11(10): 1338 - 1344.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
O. Catalano, S. Antonaci, G. Moro, M. Mussida, M. Frascaroli, M. Baldi, F. Cobelli, P. Baiardi, J. Nastoli, R. Bloise, et al.
Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities
Eur. Heart J., September 2, 2009; 30(18): 2241 - 2248.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Y. G. Yap, E. R. Behr, and A. J. Camm
Drug-induced Brugada syndrome
Europace, August 1, 2009; 11(8): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. B. Thomsen, C. Wang, N. Ozgen, H.-G. Wang, M. R. Rosen, and G. S. Pitt
Accessory Subunit KChIP2 Modulates the Cardiac L-Type Calcium Current
Circ. Res., June 19, 2009; 104(12): 1382 - 1389.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
D. Hu, H. Barajas-Martinez, E. Burashnikov, M. Springer, Y. Wu, A. Varro, R. Pfeiffer, T. T. Koopmann, J. M. Cordeiro, A. Guerchicoff, et al.
A Mutation in the {beta}3 Subunit of the Cardiac Sodium Channel Associated With Brugada ECG Phenotype
Circ Cardiovasc Genet, June 1, 2009; 2(3): 270 - 278.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Veltmann, M. Borggrefe, R. Schimpf, and C. Wolpert
Yew Causes Brugada ECG
Circulation, April 7, 2009; 119(13): 1836 - 1837.
[Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
A. O. Grant
Cardiac Ion Channels
Circ Arrhythm Electrophysiol, April 1, 2009; 2(2): 185 - 194.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Calloe, J. M. Cordeiro, J. M. Di Diego, R. S. Hansen, M. Grunnet, S. P. Olesen, and C. Antzelevitch
A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome
Cardiovasc Res, March 1, 2009; 81(4): 686 - 694.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
N. Gaborit, T. Wichter, A. Varro, V. Szuts, G. Lamirault, L. Eckardt, M. Paul, G. Breithardt, E. Schulze-Bahr, D. Escande, et al.
Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases
Eur. Heart J., February 2, 2009; 30(4): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
S. Zumhagen, T. Spieker, J. Rolinck, H. A. Baba, G. Breithardt, W. Bocker, L. Eckardt, M. Paul, T. Wichter, and E. Schulze-Bahr
Absence of Pathognomonic or Inflammatory Patterns in Cardiac Biopsies From Patients With Brugada Syndrome
Circ Arrhythm Electrophysiol, February 1, 2009; 2(1): 16 - 23.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
S. G. Priori, C. Napolitano, S. E. Humphries, and J. Skipworth
CHAPTER 9 Genetics of Cardiovascular Diseases
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
G. Antoons and K. R. Sipido
Targeting calcium handling in arrhythmias
Europace, December 1, 2008; 10(12): 1364 - 1369.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. London
Understanding Cardiac Calcium Channelopathies
Circulation, November 25, 2008; 118(22): 2221 - 2222.
[Full Text] [PDF]


Home page
CirculationHome page
P. A. Noseworthy and C. Newton-Cheh
Genetic Determinants of Sudden Cardiac Death
Circulation, October 28, 2008; 118(18): 1854 - 1863.
[Full Text] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
E. Delpon, J. M. Cordeiro, L. Nunez, P. E. B. Thomsen, A. Guerchicoff, G. D. Pollevick, Y. Wu, J. K. Kanters, C. T. Larsen, E. Burashnikov, et al.
Functional Effects of KCNE3 Mutation and Its Role in the Development of Brugada Syndrome
Circ Arrhythm Electrophysiol, August 1, 2008; 1(3): 209 - 218.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Petitprez, T. Jespersen, E. Pruvot, D. I. Keller, C. Corbaz, J. Schlapfer, H. Abriel, and J. P. Kucera
Analyses of a novel SCN5A mutation (C1850S): conduction vs. repolarization disorder hypotheses in the Brugada syndrome
Cardiovasc Res, June 1, 2008; 78(3): 494 - 504.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Francis and C. Antzelevitch
Atrial Fibrillation and Brugada Syndrome
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1149 - 1153.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P.-S. Chen and S. G. Priori
The Brugada Syndrome
J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1176 - 1180.
[Full Text] [PDF]


Home page
EuropaceHome page
S. Viskin, C. Antzelevitch, M. F. Marquez, and B. Belhassen
Quinidine: a valuable medication joins the list of 'endangered species'
Europace, December 1, 2007; 9(12): 1105 - 1106.
[Full Text] [PDF]


Home page
CirculationHome page
B. London, M. Michalec, H. Mehdi, X. Zhu, L. Kerchner, S. Sanyal, P. C. Viswanathan, A. E. Pfahnl, L. L. Shang, M. Madhusudanan, et al.
Mutation in Glycerol-3-Phosphate Dehydrogenase 1-Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias
Circulation, November 13, 2007; 116(20): 2260 - 2268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Antzelevitch
Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. N. Viswanathan and R. L. Page
Short QT: When Does It Matter?
Circulation, August 14, 2007; 116(7): 686 - 688.
[Full Text] [PDF]